Liquid nutritional product with carob extract to improve carbohydrate metabolism in people with prediabetes.
Official title: Randomized Clinical Trial on the Effect of a Nutritional Product Containing Carob Extract (NUTIFOOD) on Carbohydrate Metabolism in Glucose-intolerant Subjects
Run by Universidad Católica San Antonio de Murcia · NCT07420998 · Data updated 2026-11-12
This 90-day test will see if a liquid nutritional product containing carob extract can help improve blood sugar control in adults with prediabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Universidad Católica San Antonio de Murcia Academic / other |
| Locations | 1 site (Murcia) |
| Status | Recruiting |
| Started | January 26, 2026 |
| Main results expected | April 2026 |
| Study ends | July 2026 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT07420998 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with prediabetes (impaired fasting glucose, impaired glucose tolerance, or HbA1c 5.7–6.4%), BMI 20–35 kg/m², stable weight, and not taking antidiabetic medications are the intended participants.
✕Probably not a fit
People taking medications that affect glucose metabolism, those with liver or kidney disease, heavy alcohol use, known allergy to product components, recent trial participation, or who fall outside the age/BMI limits are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, placebo-controlled trial will compare a liquid nutritional product containing carob extract to a matching placebo over 90 days in adults with glucose intolerance. Eligible participants are 18–65 years old with impaired fasting glucose, impaired glucose tolerance, or HbA1c 5.7–6.4% and BMI 20–35 kg/m², and are not taking antidiabetic medications. Primary outcomes include glucose response during an oral glucose tolerance test (AUC and peak), changes in fasting glucose, HbA1c, basal insulin, and insulin resistance indices (HOMA-IR, QUICKI); body composition and safety/tolerability will also be recorded. The single-center study is conducted at UCAM HiTech in Murcia, Spain with scheduled metabolic testing and follow-up visits.
Why it matters
Potential benefit: If successful, this could offer a safe, non-drug option to help lower blood sugar and reduce insulin resistance in people with prediabetes.
How similar studies have gone: Small human and animal studies of carob extracts or fiber-rich carob products have suggested modest improvements in postprandial glucose, but large randomized trials in prediabetes are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects of both sexes aged 18-65 years. * Diagnosis of glucose intolerance according to the American Diabetes Association (at least one of the following criteria): * Impaired fasting glucose (100-125 mg/dl) * Impaired glucose tolerance (oral glucose tolerance test with 2-hour plasma glucose between 140-199 mg/dl) * Glycated hemoglobin between 5.7% and 6.4% * Body mass index between 20-35 kg/m². * Stable dietary habits: no weight gain or loss greater than 5 kg in the last ten weeks. * Volunteers capable of understanding the clinical study and willing to comply with the study procedures and requirements. Exclusion Criteria: * Use of medications that may interfere with glucose metabolism. * Subjects with a history of any type of hepatic or renal disease. * Alcohol consumption greater than 20 g/day. * History of allergic hypersensitivity or poor tolerance to any component of the study products. * Participation in another clinical trial within the three months prior to the study. * Lack of willingness or inability to comply with clinical trial procedures. * Pregnant or breastfeeding women.
Where it's running
-
UCAM HiTech, Sport & Health Innovation Hub
Murcia, Spain Recruiting
Study contacts
- Study coordinator: Francisco Javier López Román
- Email: jlroman@ucam.edu
- Phone: 968278157
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Hourly stair-climbing snacks to improve blood sugar and heart health in adults with prediabetes
This study tests whether short stair-climbing bursts every hour can improve blood sugar and vascular health in adults with prediabetes.
-
Smart probiotic and nutraceutical approach for cardiometabolic health in older adults
This trial tests whether a probiotic-containing nutraceutical strategy can improve metabolic health and blood pressure in adults over 65 with prediabetes or cardiovascular disease.
-
Family-based diabetes prevention for parents and kids
A family-focused program tests whether a 12-week lifestyle plan can help parents at risk for diabetes lose weight and improve healthy habits for themselves and their children aged 12–17.
-
Cardiorespiratory and muscular fitness in children with obesity and autism
This study tests whether cardiorespiratory fitness and handgrip strength differ between children with obesity who have autism and those who do not, and how these fitness measures relate to body size, composition, and cardiometabolic health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.